复方丹参

  • 网络Compound Danshen;Salvia miltiorrhiza;fufang danshen;Compound Danshen Dripping Pills
复方丹参复方丹参
  1. 目的:评价地塞米松联合复方丹参注射液辅助治疗重症急性胰腺炎(SAP)的疗效。

    AIM : To estimate the effect of dexamethasone and composite salvia miltiorrhiza injection used as adjunctive therapy for severe acute pancreatitis ( SAP ) .

  2. 结论:合理应用地塞米松联合复方丹参注射液辅助治疗SAP可显著改善其病程及预后。

    CONCLUSION : The adjunctive therapy with dexamethasone and composite salvia miltiorrhiza injection for SAP may shorten the course of disease , improve the prognosis and decrease the complications .

  3. 复方丹参对缺血预适应大鼠心肌蛋白激酶C表达的影响

    Effect of Compound Salvia Recipe on myocardial protein kinase C expression of ischemic preconditioning rat

  4. 不同厂家复方丹参片中丹参酮ⅡA、丹酚酸B含量考察

    Inspection of tanshinone ⅱ _A and salvianolic acid B in Compound Danshen Tablets from different manufacturers

  5. 对照组口服脑益嗪片、维生素C片、静滴复方丹参注射液。

    The control group was treated with oral cinnarizine , vitamine C and compund salvia miltiorrhiza intravenously .

  6. 联用复方丹参注射液和大剂量维生素C治疗急性病毒性心肌炎疗效观察

    Observation on therapeutic effect of composite salvia miltiorrhiza injection and high doses vitamin C on acute viral myocarditis

  7. HPLC测定复方丹参方中三七皂苷类成分的含量

    Determination of Saponins Content in Compound Danshen Prescription by HPLC

  8. HPLC法测定复方丹参制剂中丹参有效成分的含量

    Quantitative Determination of Active Constituents in Complex Prescription of Salvia miltiorrhiza by HPLC

  9. GC测定复方丹参口崩片中冰片的含量

    Determination of Borneol in Compound Salvia Orally Disintegrating Tablet by GC

  10. HPLC测定复方丹参片中丹参三种脂溶性成分的含量

    Determination of fat-soluble components of Salvia miltiorrhiza in Compound Salvia miltiorrhiza tablets by HPLC

  11. 复方丹参注射液对脑出血CT及脑脊液LDH的影响

    Effects of Composite Salvia Miltiorrhiza on CT and LDH of CSF during Cerebral Hemorrhage

  12. 复方丹参CO2超临界萃取液抗大鼠血栓形成的实验研究

    Experimental Study on the Antithrombotic Effects of Liquid Extraction of Salvia Miltiorrhiza Compound by CO_2 Supercritical Technology

  13. 并建立了HPLC测定方法对复方丹参片中的丹参酮ⅡA进行含量测定。

    The HPLC was established for determination of tanshinone II A in compound salvia tablets .

  14. 基于HPLC指纹图谱的系统指纹定量法评估复方丹参滴丸质量

    Quality evaluation of compound Danshen dropping pills by systematic quantified fingerprint method based on HPLC fingerprints

  15. 结果制备了复方丹参pH依赖型延迟释药微丸,体外溶出曲线呈pH依赖特征。

    Results The compound danshen pH-dependent delayed release pellets were prepared with the characteristics of pH dependent delayed release profile in vitro .

  16. 辅酶Q(10)和复方丹参对心肌线粒体呼吸链的保护作用

    Protective effect of compound radix salviae miltiorrhizae and ubiquinone _ ( 10 ) for respiration chain in myocardial mitochondria

  17. 复方丹参注射液、辅酶Q(10)治疗病毒性心肌炎疗效观察

    Observation of injection of salvia miltiorrhiza compound and coenzyme Q_ ( 10 ) in the treatment of viral myocarditis

  18. 复方丹参片中冰片的GC-MS法测定

    Determination of Borneol in Compound Salvia Tablets by GC-MS

  19. 用RP-HPLC指纹图谱控制复方丹参滴丸中低波长紫外吸收指纹成分

    Low ultraviolet absorption components in compound Danshen dropping pills controlled by RP-HPLC fingerprints

  20. 复方丹参注射液加CF方案胸腔内注射治疗恶性胸腔积液33例临床观察

    Clinical effect of Fufang Danshen injection integrated with CF by thoracic injection on malignant ascites

  21. 目的:评估UV吸收光谱在复方丹参片(滴丸)的鉴别和质量控制中的价值。

    Objective : To evaluate the value of UV absorption spectrum for identification and quality control of compound Danshen tablets and pills .

  22. 结果复方丹参片能明显降低实验性AD大鼠脑内兴奋性氨基酸Glu的含量,升高抑制性氨基酸Gly和GABA的含量。

    Results CDST significantly decreased the excitatory Glu content , and increased the inhibitory Gly and GABA contents .

  23. 复方丹参片DDDs上升了22%。

    The DDDs of compound red sage tablet increased by 22 % .

  24. 复方丹参针预防ESWL术早期肾损害的临床研究

    Clinical Study on the Protection of Compound Salvia Miltiorrhiza Injection for Early Renal Impairment After ESWL

  25. 结论:复方丹参注射液治疗HIE疗效满意,值得推广。

    Conclusion : Compound danshen injection has satisfactory curative effect to cure HIE , and is worth spreading .

  26. 肝素治疗组的HA、ⅣC、LN、PCⅢ水平均较复方丹参治疗组、α干扰素治疗组为低。

    The HA , ⅳ - C , LN and PC - ⅲ levels of heparin groups were significant lower than those of danshen and interferon-alpha treatment groups .

  27. 方法:rt-PA0.8mg·kg-1,低分子肝素、右旋糖酐40和复方丹参联合应用。

    Methods : The dose of rt-PA ( 0.8 mg · kg-1 ) combined with low molecule heparine , Dextran 40 and Red Sager Root compound .

  28. 结论复方丹参片降低兴奋性氨基酸含量,以对抗兴奋性氨基酸的毒性,这可能是其防治AD的机制之一。

    Conclusion CDST could lower the toxicity of excitatory amino acid by decreasing its contents , which may be one of the mechanisms of CDST in prevention and treatment to AD.

  29. 观察糖尿病患者服用复方丹参片后,其超氧化物歧化酶(SOD)活力和血液流变学的变化,并探讨该药在糖尿病并发症防治中的作用。

    To study treating and preventing effect of Miltiorrhizae composita tablets on complications of diabetes mellitus , superoxide dismutase ( SOD ) and hemorrheology in diabetics were observed .

  30. 结论:复方丹参注射液及胞二磷胆碱佐治新生儿HIE能提高治愈率,减轻伤残。

    Conclusions : Citicoline and salvia miltiorrhiza injection in addition to routine treatment can raise cure rate , reduce disability .